Quarterly report pursuant to Section 13 or 15(d)

Stock Incentive Plan (Tables)

v3.19.3
Stock Incentive Plan (Tables)
9 Months Ended
Sep. 30, 2019
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Schedule of Stock-Based Compensation Expense Recognized The following table reflects the components of stock-based compensation expense recognized in the Condensed Consolidated Statements of Operations for the three and nine month periods ended September 30, 2019 and 2018:

 

 

 

Three Months Ended

September 30,

 

 

Nine Months Ended

September 30,

 

 

 

2018

 

 

2019

 

 

2018

 

 

2019

 

 

 

(Dollars in thousands)

 

Stock option compensation expense included in unallocated corporate expenses

 

$

120

 

 

$

43

 

 

$

220

 

 

$

229

 

Restricted stock shares compensation expense included in unallocated corporate expenses

 

 

 

 

 

100

 

 

 

 

 

 

523

 

Stock option compensation expense included in broadcast operating expenses

 

 

40

 

 

 

20

 

 

 

82

 

 

 

88

 

Restricted stock shares compensation expense included in broadcast operating expenses

 

 

 

 

 

 

 

 

 

 

 

383

 

Stock option compensation expense included in digital media operating expenses

 

 

27

 

 

 

12

 

 

 

50

 

 

 

58

 

Stock option compensation expense included in publishing operating expenses

 

 

4

 

 

 

2

 

 

 

11

 

 

 

8

 

Total stock-based compensation expense, pre-tax

 

$

191

 

 

$

177

 

 

$

363

 

 

$

1,289

 

Tax expense for stock-based compensation expense

 

 

(49

)

 

 

(46

)

 

 

(94

)

 

 

(335

)

Total stock-based compensation expense, net of tax

 

$

142

 

 

$

131

 

 

$

269

 

 

$

954

 

 

Schedule of Weighted-Average Assumptions Used to Estimate Fair Value of Stock Options and Restricted Stock Awards using Black-Scholes Option Valuation Model

The weighted-average assumptions used to estimate the fair value of the stock options using the Black-Scholes valuation model were as follows for the three and nine month periods ended September 30, 2019 and 2018:

 

 

 

Three Months Ended

September 30, 2018

 

Nine Months Ended

September 30, 2018

 

 

Three Months Ended

September 30, 2019

 

Nine Months Ended

September 30, 2019

 

Expected volatility

 

n/a

 

41.84%

 

 

50.45%

 

50.07%

 

Expected dividends

 

n/a

 

7.89%

 

 

15.75%

 

14.91%

 

Expected term (in years)

 

n/a

 

7.4

 

 

7.7

 

7.7

 

Risk-free interest rate

 

n/a

 

2.93%

 

 

1.71%

 

1.83%

 

Schedule of Stock Option Activity

Activity with respect to the Company’s option awards during the nine month period ended September 30, 2019 is as follows:

 

Options

 

Shares

 

 

Weighted

Average

Exercise Price

 

 

Weighted

Average

Grant Date

Fair Value

 

 

Weighted

Average

Remaining

Contractual

Term

 

Aggregate

Intrinsic

Value

 

 

 

(Dollars in thousands, except weighted average exercise price and weighted average grant date fair value)

 

Outstanding at January 1, 2019

 

 

1,980,972

 

 

$

4.63

 

 

$

2.61

 

 

4.1 years

 

$

 

Granted

 

 

38,750

 

 

 

1.80

 

 

 

0.30

 

 

 

 

 

 

Exercised

 

 

(200

)

 

 

2.38

 

 

 

2.05

 

 

 

 

 

 

Forfeited or expired

 

 

(185,050

)

 

 

5.81

 

 

 

4.14

 

 

 

 

$

2

 

Outstanding at September 30, 2019

 

 

1,834,472

 

 

$

4.47

 

 

$

2.42

 

 

3.8 years

 

$

 

Exercisable at September 30, 2019

 

 

1,264,344

 

 

$

4.93

 

 

$

2.79

 

 

2.5 years

 

$

 

Expected to Vest

 

 

541,337

 

 

$

4.49

 

 

$

2.43

 

 

3.7 years

 

$

 

Schedule of Information Regarding Restricted Stock Activity

Activity with respect to the Company’s restricted stock awards during the nine month period ended September 30, 2019 is as follows:

 

Restricted Stock Awards

 

Shares

 

 

Weighted

Average

Grant Date

Fair Value

 

 

Weighted

Average

Remaining

Contractual

Term

 

 

Aggregate

Intrinsic

Value

 

 

 

(Dollars in thousands, except weighted average exercise price and weighted average grant date fair value)

 

Outstanding at January 1, 2019

 

 

 

 

$

 

 

 

 

 

$

 

Granted

 

 

430,384

 

 

 

2.11

 

 

 

 

 

 

906

 

Lapsed

 

 

(389,061

)

 

 

2.07

 

 

 

 

 

 

919

 

Forfeited

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at September 30, 2019

 

 

41,323

 

 

$

2.42

 

 

 

1.76

 

 

$

63